Upload
hisa
View
39
Download
0
Tags:
Embed Size (px)
DESCRIPTION
The population impact of ART scale-up on the risk of new HIV infection in rural KwaZulu-Natal, South Africa Frank Tanser Presentation at IAS, Kuala Lampur 02 July 2013. Outline. Background ART coverage and risk of HIV acquisition Population viral load . Global ART scale-up. - PowerPoint PPT Presentation
Citation preview
The population impact of ART scale-up on the risk of new HIV infection in rural
KwaZulu-Natal, South Africa
Frank Tanser
Presentation at IAS, Kuala Lampur02 July 2013
Outline
• Background• ART coverage and risk of HIV acquisition• Population viral load
Global ART scale-up
UNAIDS Report on the Global AIDS Epidemic 2012; WHO Universal Access Report 2013; Aaron Motsoaledi 2012
South Africa has the worldwide
largest absolute number of
patients on ART, >1.6 million by some estimates
Study setting• Adult HIV prevalence
24%
• High levels of unemployment and poverty
• Zulu-speaking population
• Former homeland under apartheid
Africa Centre for Health and Population Studies
The Africa Centre
Bor, Herbst, Newell, and Bärnighausen Science 2013
Adult life expectancy over time
13,060 deaths among 101,286individuals aged 15 years and older, contributinga total of 651,350 person-years of follow-up time
HIV incidence by age and sex 2004-2010
00.010.020.030.040.050.060.070.080.090.1
0 20 40 60 80 100
HIV
Inci
denc
e (p
er Y
ear)
Age (Years)
00.010.020.030.040.050.060.070.080.09
0.1
0 20 40 60 80 100H
IV In
cide
nce
(per
yea
r)
Age (years)
Females Males
Tanser, Bärnighausen, Newell CROI 2011
Spatial clustering of
new HIV infections
Tanser et al CROI. Boston, MA; 2011.
Outline
• Background• ART coverage and risk of HIV acquisition• Population viral load
Population-based HIV surveillance
• Since 2003: Population-based HIV surveillance– Longitudinal, dynamic cohort
– Entire adult population living in a contiguous geographical area of 438 km2 under surveillance
– Annual rounds
– 75% of those observed to be HIV-uninfected subsequently retest
– All individuals geo-located
Tanser, Hosegood, Bärnighausen et al. International Journal of Epidemiology 2007
Tanser, Bärnighausen, Grapsa, Zaidi & Newell Science 2013
ART coverage of all HIV-infected individuals 2004-2011
Adjusted for age, sex, community-level HIV prevalence, urban vs. rural locale, marital status, >1 partner in last 12 months, and household wealth index
<10% 10-20%
20-30%
30-40%
40-50%
>50%0
0.2
0.4
0.6
0.8
1
1.2
Proportion of all HIV positive people receiving ART
Adju
sted
Haz
ard
ratio
p=0.004
P<0.0001p<0.0001
P<0.0001
p=0.171
Survival analysis
> 17,000 HIV-negative individuals followed-up for HIV acquisition over 60,558 person-years1,573 HIV sero-conversionsTime- (and space-) varying demographic, sexual behavior, economic and geographic controls, including HIV prevalence
Population impact of ART coverage on risk of HIV acquisition (2004-2012)
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
<20 20-35% 35-50% 50-60% >60%
Adju
sted
haz
ard
ratio
Proportion using condom at last sex
Adjusted for age, sex, community-level HIV prevalence, urban vs. rural locale, marital status, >1 partner in last 12 months, and household wealth index
Tanser et al, Science, 2013
Population impact of condom use on risk of HIV acquisition (2005-2011)
Conclusion
• We find continued reductions in risk of acquiring HIV infection with increasing ART coverage in this typical rural sub-Saharan African setting
• However, there is evidence of a “reduction saturation” effect (at coverage of >40%) under treatment guidelines of <350 CD4+ cells/µl
Outline
• Background• ART coverage and risk of HIV acquisition• Population viral load
Population/Community viral load
• Proposed as:–an aggregate measure of the potential for ongoing HIV transmission within a community
–as a surveillance measure for monitoring uptake and effectiveness of antiretroviral therapy.
Figure 1
Miller, Powers, Smith et al Lancet Infectious Diseases 2013
CVC as a measure for assessment of HIV
treatment as prevention
CVC as a measure for assessment of HIV
treatment as prevention“ The issue of selection bias [in community viral load] could be addressed with a population-based survey in a clearly defined target population of all people in a community, including those with and without known HIV infection”
Miller, Powers, Smith et al Lancet Infectious Diseases 2013
Objectives1. Asses whether viral loads in this
population are randomly distributed in space or whether high or low viral loads tend to cluster in certain areas
2. Assess the degree to which different population viral load summary measures highlight known areas of high incidence
3. (Establish the degree to which different population viral load summary measures predict future risk of new HIV infection in uninfected individuals)
Methods• All 2,456 individuals testing positive in the
population-based HIV testing conducted in 2011
• Total number DBS specimens tested was 2,420 (36 specimens excluded due to being insufficient for testing).
• Of these, 30% (726) were below the detectable limit of 1550 copies/ml (Viljoen et al, JAIDS 2010)
01.
0e-0
62.
0e-0
63.
0e-0
6D
ensi
ty
0 2000000 4000000 6000000 8000000 10000000VL Result (copies/ml)
Viral load distribution
Median viral load = 6428 copies per ml
Geometric mean population viral load
Copies /ml
Prevalence of unsuppressed viral load
Prevalence (%)
1.00
1.50
2.00
2.50
3.00
3.50
<10% 10 - 15% 15-20% 20-25% >25%
Adju
sted
haz
ard
ratio
HIV Prevalence
p=0.001
p<0.0001p<0.0001
p=0.034
Adjusted HIV acquisition hazard by prevalence category
Adjusted for age, sex, community-level HIV prevalence, urban vs. rural locale, marital status, >1 partner in last 12 months, and household wealth index
Population prevalence of detectable virus (PPDV)
Prevalence(%)
Conclusion• To measure transmission potential of a
community, any viral load summary index must take into account the size of the uninfected population
• Population prevalence of detectable virus (PPDV) successfully identified known areas of continued high HIV incidence
• We propose the PPDV as a simple community-level index of transmission potential
Acknowledgements• The members of the community in Hlabisa sub-
district who gave their time to this research• Staff of the Africa Centre for Health and
Population Studies and the Hlabisa HIV Care and Treatment Programme
• Colleagues at Africa Centre (Marie-Louise Newell, Till Bärnighausen, Tulio de Oliveira,Kobus Herbst, Colin Newell, Jacob Bor, Jaffer Zaidi and many more)
• Funding− Wellcome Trust (Africa Centre for Health and
Population Studies)− National Institutes of Health grants R01 HD058482-
01 and 1R01MH083539-01